osteochondrodysplasia: A term referring to disorders characterized by abnormalities in the development of bones and cartilage.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
318 |
4. Check minimum number of eventsNone |
318 |
5. Include endpointsNone |
318 |
6. Filter based on genotype QC (FinnGen only) |
318 |
Control definitions (FinnGen only)
- Control exclude
- Q17_CONGEN_MALFO_DEFORMAT_MUSCULOS_SYSTEM
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- Q6[5-9]|Q7
- Name in latin
- Aliae osteochondrodysplasiae
Similar endpoints
↥List of similar endpoints to
Other osteochondrodysplasias
based on the number of shared cases.
Similar with more cases:
- Congenital malformations and deformations of the musculoskeletal system
- Congenital malformations, deformations and chromosomal abnormalities
- Any operation in hilmo
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 2943 | 1494 | 1438 |
| Only index persons | 2617 | 1336 | 1281 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.04 | 0.04 | 0.04 |
| Only index persons | 0.05 | 0.05 | 0.05 |
| Median age at first event (years) | |||
| Whole population | 20.01 | 23.59 | 15.99 |
| Only index persons | 22.24 | 27.33 | 16.94 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 318 | 194 | 124 |
| Unadjusted period prevalence (%) | 0.06 | 0.07 | 0.05 |
| Median age at first event (years) | 36.26 | 36.16 | 36.41 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 292
- Matched controls
- 2920
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
Q78.00
ICD-10 Finland
Congenital osteogenesis imperfecta
+∞
89.2
81
*
Q78.6
ICD-10 Finland
Multiple congenital exostoses
+∞
79.9
73
*
Q78.9
ICD-10 Finland
Osteochondrodysplasia, unspecified
+∞
45.0
42
*
Q78.48
ICD-10 Finland
Enchondromatosis
+∞
36.2
34
*
Z31.5
ICD-10 Finland
Genetic counselling
9.3
32.9
73
101
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
11.0
32.6
65
74
Q78.1
ICD-10 Finland
Polyostotic fibrous dysplasia
+∞
27.5
26
*
NF3AA
NOMESCO Finland
Femur X-ray examination
35.7
25.2
32
10
Q78.08
ICD-10 Finland
Osteogenesis imperfecta tarda
+∞
24.3
23
*
7564A
ICD-9 Finland
Other congenital musculoskeletal anomalies, Chondrodystrophy
+∞
23.2
22
*
NA2AA
NOMESCO Finland
Thoracal spine X-ray examination without contrast
16.8
23.2
37
25
NG4AA
NOMESCO Finland
Lower leg X-ray examination
13.1
22.0
39
34
Q78.88
ICD-10 Finland
Other specified osteochondrodysplasias
+∞
20.0
19
*
75650
ICD-8 Finland
Other congenital anomalies of musculoskeletal system, Chondrodystrophy
+∞
20.0
19
*
Q78.2
ICD-10 Finland
Osteopetrosis
+∞
20.0
19
*
D16.2
ICD-10 Finland
Benign neoplasm: Long bones of lower limb
+∞
19.0
18
*
D48.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Bone and articular cartilage
23.6
18.5
26
12
NE1AA
NOMESCO Finland
Pelvis X-ray examination
8.7
18.3
40
52
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
5.2
16.5
54
122
S72.3
ICD-10 Finland
Fracture of shaft of femur
30.5
15.4
20
7
Q78.40
ICD-10 Finland
Enchondromatosis
+∞
14.7
14
*
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
3.0
14.2
102
446
NFU20
NOMESCO Finland
Removal of internal fixation device from femur
25.3
14.0
19
8
R4110
NOMESCO Finland
Physiotherapy
2.9
13.7
104
469
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.9
13.2
97
428
S82.2
ICD-10 Finland
Fracture of shaft of tibia
15.0
13.0
21
15
NFJ60
NOMESCO Finland
Internal fixation of fracture of other parts of femur with intramedullary nail
33.7
12.7
16
5
D16.1
ICD-10 Finland
Benign neoplasm: Short bones of upper limb
73.1
12.7
14
*
9165
FHL
Removal of osteosynthesis material
18.4
12.7
19
11
TNX34
NOMESCO Finland
Major custom molded cast, unspecified region
10.4
12.5
24
25
ZXA05
NOMESCO Finland
Left side
3.0
12.2
84
351
M05BA04
ATC
alendronic acid; oral
6.0
12.2
34
63
NF1AA
NOMESCO Finland
Hip X-ray examination
5.5
12.1
36
73
H90.6
ICD-10 Finland
Mixed conductive and sensorineural hearing loss, bilateral
12.5
11.5
20
17
WX1PA
NOMESCO Finland
Total body mineral density measurement with Dual energy X-ray absorptiometry (DXA)
36.6
11.4
14
*
NJ3DA
NOMESCO Finland
Long bones of extremities X-ray examination
36.6
11.4
14
*
L28
ICPC
Limited function/disability (L)
3.8
11.3
50
151
M81.9
ICD-10 Finland
Osteoporosis, unspecified
10.2
10.9
21
22
NFK30
NOMESCO Finland
Angulation, rotation or displacement osteotomy of femur
62.3
10.7
12
*
NK6MA
NOMESCO Finland
Measurement of bone age from hand and elbow using X-ray
8.2
10.6
23
30
TNX33
NOMESCO Finland
Custom moulded cast, unspecified region
5.3
10.3
31
64
DFF00
NOMESCO Finland
Pure tone audiometry
4.3
9.7
36
93
X59
ICD-10 Finland
Exposure to unspecified factor
2.6
9.6
76
343
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
3.5
9.5
46
149
H90.0
ICD-10 Finland
Conductive hearing loss, bilateral
31.1
9.5
12
*
NGK30
NOMESCO Finland
Angulation, rotation or displacement osteotomy of knee or lower leg
103.2
9.5
10
*
Q78.80
ICD-10 Finland
Osteopoiesis
+∞
9.4
9
*
X58
ICD-10 Finland
Exposure to other specified factors
2.9
9.3
60
238
NE1AD
NOMESCO Finland
Pelvis and hip bones CT examination
16.2
9.1
14
9
NFR20
NOMESCO Finland
Incomplete excision of soft tissue tumour of hip or thigh
37.9
9.1
11
*
5BA08
NOMESCO Finland
NA
19.3
9.0
13
7
ZXA00
NOMESCO Finland
Right side
2.5
9.0
79
375
9102
FHL
Trepanation or removal of the local bone process
24.9
9.0
12
5
M05BA07
ATC
risedronic acid; oral
8.6
8.7
18
22
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
3.6
8.7
39
119
Z3226
NOMESCO Finland
Physiotherapist
2.5
8.6
75
355
ZXD10
NOMESCO Finland
Scheduled procedure
2.2
8.5
118
693
NGR20
NOMESCO Finland
Intralesional or marginal excision of tumor of knee or lower leg
92.6
8.5
9
*
5BA03
NOMESCO Finland
NA
+∞
8.4
8
*
NFK10
NOMESCO Finland
Fenestration or partial or total excision of bone of femur
+∞
8.4
8
*
K00.51
ICD-10 Finland
Dentinogenesis imperfecta
+∞
8.4
8
*
M85.0
ICD-10 Finland
Fibrous dysplasia (monostotic)
+∞
8.4
8
*
D16.0
ICD-10 Finland
Benign neoplasm: Scapula and long bones of upper limb
+∞
8.4
8
*
H05BA01
ATC
calcitonin (salmon synthetic); nasal, parenteral
8.5
8.2
17
21
NA1AA
NOMESCO Finland
Cervical spine X-ray examination without contrast
6.6
8.2
20
32
RK110
NOMESCO Finland
NA
34.4
8.1
10
*
ZXE10
NOMESCO Finland
More than one and less than three hours
2.2
8.1
111
647
M79.6
ICD-10 Finland
Pain in limb
2.1
8.0
109
634
SPAT1229
SPAT
Assessment of need for aid
4.7
8.0
26
59
TNX50
NOMESCO Finland
Removal of cutom molded cast and internal stretch
4.3
7.8
28
70
ZXE20
NOMESCO Finland
More than three and less than five hours
2.8
7.8
52
210
N02BE01
ATC
paracetamol; systemic, rectal
2.3
7.7
235
1887
Z01.1
ICD-10 Finland
Examination of ears and hearing
2.7
7.6
54
226
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
3.1
7.6
42
148
E883A
ICD-9 Finland
Fall into hole or other opening in surface
5.6
7.5
21
40
NBR20
NOMESCO Finland
Intralesional or marginal excision of soft tissue tumour of shoulder or upper arm
82.1
7.4
8
*
3870A
ICD-9 Finland
Otosclerosis involving oval window, nonobliterative
82.1
7.4
8
*
NDR20
NOMESCO Finland
Incomplete excision of soft tissue tumour of wrist or hand
8.7
7.4
15
18
NGU20
NOMESCO Finland
Removal of internal fixation device from knee or lower leg
9.7
7.4
14
15
ZZH21
NOMESCO Finland
Graft of patients own bone, small pieces
9.7
7.4
14
15
RK120
NOMESCO Finland
NA
+∞
7.3
7
*
NFK99
NOMESCO Finland
Other operation on bone of femur
+∞
7.3
7
*
7565A
ICD-9 Finland
Other congenital musculoskeletal anomalies, Osteodystrophies
+∞
7.3
7
*
N02AX02
ATC
tramadol; systemic, rectal
2.1
7.3
110
663
NB6AA
NOMESCO Finland
Humerus X-ray examination
12.4
7.1
12
10
EBA15
NOMESCO Finland
Extraction of large number of teeth
5.4
7.1
20
39
NH1AA
NOMESCO Finland
Ankle X-ray examination without contrast
3.7
7.1
30
88
NCU20
NOMESCO Finland
Removal of internal fixation device from elbow or forearm
17.2
6.8
10
6
S42.1
ICD-10 Finland
Fracture of scapula
17.2
6.8
10
6
H80.0
ICD-10 Finland
Otosclerosis involving oval window, nonobliterative
23.1
6.7
9
*
AA1AA
NOMESCO Finland
Head X-ray examination
12.6
6.6
11
9
ZXE00
NOMESCO Finland
One hour or less
1.9
6.5
127
833
NE1CG
NOMESCO Finland
Pelvic, hip and femur extensive MRI examination with high intensity magnet
7.7
6.5
14
19
S32.4
ICD-10 Finland
Fracture of acetabulum
71.3
6.4
7
*
7569X
ICD-9 Finland
Other congenital musculoskeletal anomalies, Other and unspecified anomalies of musculoskeletal system
71.3
6.4
7
*
NGJ60
NOMESCO Finland
Internal fixation of fracture of knee or lower leg using intramedullary nail, other or unspecified
14.7
6.4
10
7
WX204
NOMESCO Finland
Axillary plexus blockaced
6.2
6.4
16
27
L99
ICPC
Musculoskeletal disease other
9.6
6.3
12
13
Z01.0
ICD-10 Finland
Examination of eyes and vision
2.3
6.3
59
287
75665
ICD-8 Finland
Other congenital anomalies of musculoskeletal system, Exostosis cartilaginea multiplex
+∞
6.3
6
*
L82
ICPC
Congenital anomaly musculoskeletal
+∞
6.3
6
*
NFB60
NOMESCO Finland
Demanding prosthetic replacement of hip
27.3
6.3
8
*
WX408
NOMESCO Finland
General anesthesy, balanced
2.0
6.2
92
542
L13
ICPC
Hip symptom/complaint
2.7
6.2
43
178
ZX120
NOMESCO Finland
Intravenous
2.9
6.1
36
135
WX212
NOMESCO Finland
Femoral plexus blockade
8.9
6.1
12
14
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
2.8
6.1
39
154
TPH04
NOMESCO Finland
Cathetrisation of vein
2.2
6.0
63
320
Z3229
NOMESCO Finland
Other healthcare associate professional
3.0
6.0
34
123
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
53
7
90.20
48.67
4.3
1.6
ug/l
105.4
55.7
—
53
7
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
193
1021
3.26
23.47
5.6
2.5
nmol/l
78.6
75.1
1.04
188
934
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
196
1101
3.03
20.46
10.5
7.7
mmol/l
1.2
1.2
0.23
173
943
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
186
1017
3.00
20.37
10.1
7.2
mmol/l
1.2
1.2
0.27
180
941
(3018418) pH of Serum or Plasma
133
634
2.89
18.34
6.3
3.6
ph
7.4
7.4
1.19
25
112
(3009508) Creatinine [Moles/volume] in Urine
132
701
2.51
13.87
4.8
3.4
mmol/l
7.2
8.1
1.04
121
605
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
244
1842
2.40
9.97
9.1
6.8
u/l
90.5
82.3
1.33
239
1732
(3052851) Hemolysis interference index of Serum or Plasma
25
66
4.03
8.69
2.0
2.3
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
142
916
1.99
8.19
2.0
1.9
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
117
726
1.97
7.38
3.9
3.0
mmol/l
2.4
2.4
0.05
109
651
(3000991) Gas panel - Venous blood
50
231
2.38
6.66
6.8
9.6
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
46
205
2.45
6.63
11.3
9.8
mmol/l
25.9
25.0
1.04
46
205
(42870588) Differential panel, method unspecified - Blood
132
878
1.86
6.58
6.9
6.7
—
—
—
0
0
(3002256) Pathology report gross observation
55
269
2.26
6.43
1.5
1.2
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
84
489
1.98
6.22
5.5
4.3
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
27
98
2.92
5.79
1.6
2.4
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
196
1513
1.77
5.63
10.1
9.9
e9/l
3.8
3.9
0.60
162
1330
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
14
34
4.26
5.41
1.0
1.2
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
11
22
5.14
5.30
2.2
2.0
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
162
1205
1.70
5.14
7.5
6.7
%
0.6
0.7
0.62
152
1144
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
13
31
4.33
5.14
1.4
1.1
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
167
1254
1.70
5.10
7.6
6.8
%
8.4
8.3
0.08
155
1197
(3002030) Lymphocytes/100 leukocytes in Blood
171
1297
1.69
5.00
7.5
6.5
%
29.7
30.6
0.46
159
1234
(3013115) Eosinophils [#/volume] in Blood
178
1370
1.68
4.87
7.4
7.1
e9/l
0.2
0.2
0.23
144
1223
(3001604) Monocytes [#/volume] in Blood
173
1322
1.68
4.87
7.3
6.6
e9/l
0.6
0.6
0.10
141
1148
(3002032) Base excess in Venous blood by calculation
47
241
2.12
4.86
5.1
7.0
mmol/l
1.4
2.0
0.59
41
181
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
25
96
2.74
4.86
2.0
1.6
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
165
1246
1.67
4.85
7.5
6.5
%
2.8
2.9
0.47
153
1180
(3013826) Glucose [Moles/volume] in Serum or Plasma
181
1401
1.68
4.84
5.0
5.1
mmol/l
6.2
6.5
1.10
173
1282
(3006315) Basophils [#/volume] in Blood
173
1329
1.66
4.71
7.3
6.6
e9/l
0.0
0.0
0.86
141
1159
(3019198) Lymphocytes [#/volume] in Blood
177
1368
1.66
4.71
7.4
6.6
e9/l
1.9
2.1
0.98
147
1221
(3025159) Blasts/100 leukocytes in Blood
36
168
2.29
4.68
5.6
4.6
%
0.2
0.0
—
6
42
(3027801) Oxygen [Partial pressure] in Arterial blood
41
203
2.17
4.63
7.2
10.7
kpa
14.4
12.9
0.78
41
196
(3003396) Base excess in Arterial blood by calculation
41
203
2.17
4.63
7.1
10.8
mmol/l
1.2
1.3
0.07
33
165
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
41
203
2.17
4.63
7.2
10.7
kpa
5.1
5.3
0.37
41
196
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
89
576
1.76
4.58
2.6
2.3
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
15
44
3.53
4.52
2.2
4.2
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
110
760
1.68
4.45
2.7
2.3
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
167
1284
1.63
4.44
7.4
6.3
%
55.2
55.0
0.05
157
1223
(3009214) Lutropin [Units/volume] in Serum or Plasma
30
134
2.37
4.31
1.6
1.5
u/l
12.9
8.7
0.56
21
98
(3021589) Normoblasts [#/volume] in Blood
157
1210
1.59
3.99
10.0
9.4
e9/l
0.0
0.0
0.40
118
983
(3002179) Metamyelocytes/100 leukocytes in Blood
34
167
2.16
3.92
4.6
4.5
%
0.7
0.6
—
6
38
(3017181) Myelocytes/100 leukocytes in Blood
37
189
2.08
3.87
5.6
4.4
%
1.0
1.1
—
6
55
(3051651) Icteric interference index of Serum or Plasma
9
16
5.75
3.68
2.2
1.8
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
53
315
1.82
3.58
2.3
1.8
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
147
1139
1.54
3.51
4.2
4.1
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
32
164
2.06
3.33
1.8
1.5
iu/l
20.4
20.5
0.01
25
129
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
22
97
2.36
3.28
6.7
11.0
mmol/l
24.2
24.8
0.43
22
89
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
110
810
1.55
3.26
2.0
1.8
pmol/l
102.6
98.9
0.30
54
398
(3023520) Reticulocytes [#/volume] in Blood
32
166
2.03
3.23
2.6
3.5
e9/l
80.4
71.3
0.47
23
125
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
111
822
1.54
3.20
4.5
3.3
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
0
83
0.00
3.17
0.0
1.3
—
—
—
0
0
(3002173) Hemoglobin [Mass/volume] in Arterial blood
32
169
1.99
3.08
8.6
11.7
g/l
116.6
121.9
0.92
32
163
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
10
29
3.53
3.07
1.2
1.2
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
6
8
7.62
3.06
2.0
1.9
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
33
177
1.96
3.05
6.0
4.5
%
0.0
0.2
—
5
48
(3042631) Mycobacterium sp identified in Specimen
9
21
4.38
3.01
2.6
3.7
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
89
636
1.55
2.98
3.3
2.6
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
90
647
1.55
2.93
4.8
3.3
e6/l
0.2
0.3
0.80
67
491
(3026782) Osmolality of Urine
68
458
1.62
2.92
3.6
2.7
mosm/kgh2o
563.8
562.8
0.01
55
393
(3013707) Erythrocyte sedimentation rate by Westergren method
216
1858
1.51
2.90
4.8
4.0
mm/h
11.6
9.5
1.57
205
1729
(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay
6
9
6.77
2.88
1.2
2.2
%
148.5
140.9
—
6
9
(36304419) Bacteria [Presence] in Urine
89
642
1.54
2.85
4.8
3.2
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
39
227
1.82
2.83
2.2
1.6
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
112
850
1.49
2.81
5.3
3.8
e6/l
31.4
65.2
0.71
75
592
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
8
18
4.53
2.81
1.5
1.4
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
38
221
1.82
2.76
2.2
1.6
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
120
927
1.47
2.75
5.5
5.2
g/l
36.1
37.0
1.08
111
875
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
263
2377
1.62
2.68
5.3
4.5
mu/l
1.7
2.4
0.69
248
2207
(40758558) Short blood count panel - Blood
93
686
1.50
2.66
6.8
7.6
—
—
—
0
0
(3019060) Gas panel - Arterial blood
23
114
2.10
2.63
6.2
8.2
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
33
187
1.85
2.61
8.5
11.0
%
97.3
95.8
1.26
33
181
(3024928) Oxygen saturation in Venous blood
11
38
2.96
2.61
4.0
9.9
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
96
716
1.49
2.60
4.8
3.3
e6/l
27.3
134.8
0.63
70
554
(3014576) Chloride [Moles/volume] in Serum or Plasma
41
249
1.74
2.59
7.1
8.2
mmol/l
104.8
104.5
0.15
41
241
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
8
20
4.08
2.58
3.6
5.5
ug/l
0.4
2.5
—
8
20
(40768443) Skin Pathology biopsy report
19
88
2.23
2.56
1.1
1.2
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
10
33
3.10
2.55
1.5
1.5
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
103
787
1.46
2.45
7.0
6.2
inr
1.1
1.2
0.40
35
245
(40761511) CBC panel - Blood by Automated count
295
2764
1.93
2.45
14.1
10.3
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
51
335
1.62
2.42
2.0
2.1
umol/l
14.4
14.6
0.08
44
308
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
20
98
2.11
2.37
3.2
6.0
%
1.2
1.5
0.64
20
98
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
148
1214
1.41
2.37
6.3
6.2
umol/l
11.2
11.5
0.07
138
1150
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
55
371
1.58
2.34
4.2
3.1
e6/l
3.3
2.1
0.57
28
208
(3027945) Reticulocytes/100 erythrocytes in Blood
38
234
1.71
2.30
2.7
3.9
%
1.9
1.7
0.60
32
218
(3019309) Folate [Moles/volume] in Red Blood Cells
48
315
1.62
2.29
1.4
1.6
nmol/l
1187.5
1198.5
0.03
38
240
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
6
13
4.68
2.28
1.2
1.8
%
107.3
124.8
—
6
13
(3000850) Epithelial cells [#/volume] in Urine
68
486
1.51
2.24
3.7
2.5
e6/l
6.1
5.3
0.25
57
424
(3019230) Fractional oxyhemoglobin in Venous blood
10
36
2.84
2.22
4.3
9.5
%
75.1
65.4
—
10
36
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
32
192
1.74
2.13
12.3
5.3
mmol/l
1.4
1.1
0.11
25
133
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
251
2282
1.47
2.11
14.5
9.9
ml/min/173m2
93.9
89.8
2.00
224
1800
(3037467) Urinalysis macro (dipstick) panel - Urine
195
1698
1.38
2.09
4.8
4.1
—
—
—
0
0
(3022313) Gas panel - Capillary blood
29
171
1.77
2.05
12.3
5.1
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
8
26
3.13
2.02
1.6
1.4
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
55
385
1.52
1.99
4.1
3.0
e6/l
1.2
0.7
0.63
28
220
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
32
196
1.70
1.99
3.1
3.1
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
12
51
2.41
1.97
3.2
7.1
u/ml
0.4
0.4
—
7
28
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
56
395
1.51
1.96
1.6
1.6
pmol/l
182000472.0
463.3
0.49
50
339
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
8
27
3.01
1.95
2.4
1.6
pg
31.6
32.1
—
8
27
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
8
27
3.01
1.95
1.0
1.4
—
—
—
0
0
(3019225) pH of Specimen
30
183
1.71
1.90
4.2
4.3
—
—
—
0
0
(3011648) Oxygen content in Venous blood
7
22
3.23
1.89
5.3
14.4
%
12.0
12.6
—
7
22
(3028626) Oxygen [Partial pressure] in Capillary blood
22
123
1.85
1.85
15.0
5.9
kpa
9.9
9.5
0.50
22
114
(3004789) Transferrin [Mass/volume] in Serum or Plasma
44
300
1.54
1.80
2.0
2.2
g/l
2.5
2.5
0.29
39
280
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
225
2032
1.37
1.76
4.9
3.9
pmol/l
14.4
14.6
0.48
211
1866
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
41
277
1.55
1.75
2.1
2.2
%
23.3
24.1
0.11
36
243
(3007853) Bacteria identified in Skin by Aerobe culture
43
294
1.53
1.74
1.9
1.6
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
13
61
2.18
1.74
2.8
1.1
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
13
61
2.18
1.74
2.8
1.1
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
14
68
2.11
1.73
1.4
2.1
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
25
149
1.74
1.72
1.4
2.5
u/l
2075.6
4099.0
—
7
64
(1616796) Gas panel - Central venous blood
11
48
2.34
1.72
2.2
3.6
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
65
486
1.42
1.70
2.9
3.4
ng/l
2507.5
750.1
1.17
50
403
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
13
62
2.14
1.68
1.9
2.3
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
7
25
2.84
1.66
1.3
1.1
—
—
—
0
0
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
7
25
2.84
1.66
1.3
1.2
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
23
136
1.75
1.64
2.6
2.0
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
5
14
3.61
1.62
2.8
4.0
—
—
—
0
0
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
17
92
1.90
1.59
2.2
5.6
%
153.7
172.0
0.58
17
92
(3024891) Influenza virus A+B Ag [Presence] in Specimen
19
107
1.82
1.58
1.9
1.1
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
42
293
1.50
1.56
1.8
2.1
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
41
285
1.50
1.55
1.7
1.4
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
10
44
2.31
1.54
1.8
1.7
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
5
15
3.37
1.53
1.0
2.0
—
—
—
0
0
(3027315) Oxygen [Partial pressure] in Blood
11
51
2.20
1.52
2.3
3.7
kpa
9.7
8.9
0.42
11
51
(3013290) Carbon dioxide [Partial pressure] in Blood
11
51
2.20
1.52
2.3
3.7
kpa
6.1
4.9
1.16
11
51
(3023419) Bacteria identified in Sputum by Culture
6
21
2.89
1.51
1.7
2.5
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
14
72
1.99
1.51
2.0
2.4
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
13
65
2.04
1.51
1.4
1.4
ug/g
386.4
320.5
—
7
39
(3011397) Hemoglobin [Presence] in Urine by Test strip
71
553
1.37
1.46
3.8
3.4
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
7
28
2.53
1.46
1.6
4.4
—
—
—
0
0
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
5
16
3.16
1.44
1.4
1.0
%
89.2
89.5
—
5
16
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
5
16
3.16
1.44
1.4
1.0
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
18
103
1.79
1.44
6.6
13.6
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
31
450
0.66
1.43
1.8
1.6
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
19
111
1.76
1.42
8.1
11.2
mmol/l
24.8
24.8
0.02
19
104
(3017143) Hepatitis C virus Ab [Presence] in Serum
52
386
1.42
1.42
1.4
1.5
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
74
583
1.35
1.42
3.0
2.3
mg/l
2.7
3.0
0.57
63
499
(40760888) Immunoglobulin light chains.free panel - Serum
7
29
2.44
1.40
2.3
4.0
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
77
613
1.34
1.38
5.9
4.8
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
5
17
2.97
1.36
1.0
1.1
—
—
—
0
0
(3044889) 12 lead EKG panel
179
1597
1.28
1.35
3.9
3.2
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
71
562
1.34
1.32
3.1
3.9
mg/mmol
7.1
10.1
0.38
43
361
(3012516) Albumin [Mass/volume] in Urine
68
536
1.34
1.30
2.8
3.2
mg/l
48.2
203.3
0.65
42
355
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
276
2616
1.42
1.30
16.2
11.4
mg/l
22.7
20.4
0.58
223
1961
(3035637) Corticotropin [Mass/volume] in Plasma
9
45
2.03
1.24
1.8
1.6
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
10
49
2.07
1.23
1.8
2.3
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
8
37
2.19
1.22
1.3
1.6
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
16
94
1.74
1.20
1.6
1.6
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
5
20
2.52
1.15
1.2
1.1
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
11
58
1.93
1.13
1.5
1.4
—
—
—
0
0
(3024731) MCV [Entitic volume]
307
2988
1.79
1.10
23.9
16.9
fl
89.7
89.7
0.00
307
2958
(3035941) MCH [Entitic mass]
307
2988
1.79
1.10
23.9
16.8
pg
29.9
30.0
0.54
307
2957
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
5
21
2.40
1.09
1.2
1.4
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
136
1198
1.24
1.07
3.0
2.8
ug/l
96.8
98.7
0.04
126
1120
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
7
33
2.15
1.06
1.1
1.6
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
19
122
1.59
1.05
1.7
1.3
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
307
2991
1.76
1.04
24.1
17.0
g/l
135.2
136.6
0.93
307
2959
(3021601) Nitrite [Presence] in Urine by Test strip
137
1211
1.23
1.04
5.4
4.6
estimate
0.0
0.0
0.00
34
238
(3044941) Cell count panel - Synovial fluid
5
22
2.29
1.03
1.8
1.2
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
9
50
1.82
0.97
9.1
3.9
mmol/l
3.8
3.9
—
9
43
(3008898) HLA-B27 [Presence]
8
146
0.54
0.95
1.0
1.1
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
29
210
1.42
0.94
4.0
8.0
mmol/l
7.3
6.9
0.17
29
204
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
286
2755
1.38
0.94
11.8
9.2
u/l
27.9
27.2
0.27
281
2678
(3022217) INR in Platelet poor plasma by Coagulation assay
29
211
1.41
0.92
30.3
18.8
inr
1.2
1.2
—
6
38
(3042111) Morphology [Interpretation] in Bone marrow Narrative
6
28
2.16
0.92
2.7
2.3
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
135
1204
1.21
0.91
4.0
3.3
estimate
0.0
0.0
0.00
30
231
(3009261) Glucose [Presence] in Urine by Test strip
137
1224
1.21
0.91
4.0
3.4
estimate
0.0
0.0
0.00
33
226
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
22
152
1.48
0.91
2.4
1.6
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
26
186
1.43
0.90
4.0
4.8
ug/l
5.2
6.6
0.18
17
149
(40768797) Stomach Pathology biopsy report
39
300
1.34
0.90
1.4
1.2
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
58
474
1.27
0.87
1.7
1.4
nmol/l
25.1
21.6
0.94
53
401
(3021901) Oxygen saturation in Capillary blood
6
30
2.02
0.87
3.2
2.6
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
8
44
1.84
0.86
1.4
1.3
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
75
635
1.24
0.84
4.4
3.6
estimate
0.0
0.0
0.50
32
236
(3026493) Urate [Moles/volume] in Serum or Plasma
66
552
1.25
0.82
2.1
3.1
umol/l
335.0
4317.9
1.53
60
489
(3025468) Yersinia sp identified in Specimen by Organism specific culture
6
32
1.89
0.82
2.0
1.6
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
6
33
1.83
0.79
2.0
1.6
—
—
—
0
0
(4062490)
6
33
1.83
0.79
1.3
1.2
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
6
33
1.83
0.79
2.0
1.6
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
6
33
1.83
0.79
2.0
1.6
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
6
33
1.83
0.79
2.0
1.6
—
—
—
0
0
(40761535) Cells panel - Urine sediment
24
174
1.41
0.79
2.8
3.2
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
53
435
1.26
0.78
1.3
1.3
iu/ml
10.0
28.8
3.33
12
132
(3048689) Calprotectin [Mass/mass] in Stool
51
417
1.27
0.77
3.4
2.4
ug/g
117.8
106.7
0.11
39
331
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
6
34
1.78
0.76
1.2
1.1
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
28
0.00
0.76
0.0
1.8
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
6
106
0.56
0.74
1.3
1.4
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
6
108
0.55
0.74
1.3
1.5
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
21
151
1.42
0.73
2.4
1.6
—
—
—
0
0
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
7
39
1.81
0.73
5.1
3.0
u/ml
144.1
39.0
—
7
39
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
5
26
1.94
0.71
1.6
1.6
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
13
85
1.55
0.70
1.5
2.5
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
98
868
1.19
0.69
3.1
3.4
u/l
33.1
30.8
0.27
92
837
(3020891) Body temperature
12
77
1.58
0.69
7.9
5.2
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
80
696
1.20
0.69
1.8
1.9
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
21
153
1.40
0.69
2.2
1.4
mu/l
268.2
316.2
0.59
21
138
(3004716) Salmonella sp identified in Stool by Organism specific culture
12
179
0.66
0.68
1.3
1.2
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
23
303
0.74
0.67
1.5
1.9
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
46
380
1.25
0.65
3.5
3.1
ng/l
51.0
237.5
1.95
38
250
(3000330) Specific gravity of Urine by Test strip
14
95
1.50
0.65
2.8
2.8
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
63
539
1.21
0.65
1.6
2.4
mg/l
2.4
1.0
0.51
48
413
(3017446) Testosterone [Moles/volume] in Serum or Plasma
26
199
1.33
0.65
2.2
2.3
nmol/l
12.7
13.5
0.16
20
186
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
6
103
0.57
0.63
1.7
1.5
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
6
105
0.56
0.62
1.3
1.4
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
5
30
1.68
0.61
1.0
1.2
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
0
20
0.00
0.60
0.0
1.6
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
0
20
0.00
0.60
0.0
1.5
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
0
21
0.00
0.60
0.0
1.4
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
8
52
1.55
0.60
2.0
1.7
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
0
23
0.00
0.58
0.0
1.4
—
—
—
0
0
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
8
54
1.49
0.57
1.1
3.3
e6/l
218.9
259.7
—
8
45
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
8
55
1.47
0.56
1.4
1.3
ug/l
1.6
3.3
—
8
49
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
190
1794
1.15
0.56
3.1
3.2
u/l
41.2
41.6
0.02
177
1719
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
9
61
1.49
0.54
1.7
1.2
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
9
62
1.46
0.53
1.2
1.3
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
24
188
1.30
0.53
2.2
1.6
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
24
188
1.30
0.53
2.2
1.6
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
24
188
1.30
0.53
2.3
1.6
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
6
99
0.60
0.52
2.7
2.2
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
234
2421
0.87
0.46
4.1
4.0
mmol/l
4.8
4.7
0.25
220
2271
(3007566) Smooth muscle Ab [Titer] in Serum
5
83
0.60
0.46
1.4
1.4
—
59.0
—
0
10
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
7
49
1.44
0.46
1.1
1.2
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
236
2440
0.87
0.46
4.6
4.3
mmol/l
2.9
2.8
0.42
221
2278
(3050129) First trimester maternal screen panel - Serum or Plasma
11
152
0.71
0.45
1.5
1.4
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
22
176
1.27
0.43
2.4
1.6
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
8
56
1.44
0.43
1.9
2.4
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
6
94
0.63
0.43
1.0
1.4
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
24
293
0.80
0.42
2.3
1.9
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
225
2169
1.13
0.41
5.0
4.9
mmol/mol
38.3
38.8
0.35
215
2052
(3024522) Salmonella sp identified in Specimen by Organism specific culture
5
33
1.52
0.41
2.2
1.6
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
10
138
0.72
0.41
1.4
1.5
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3027231) Wheat IgE Ab [Units/volume] in Serum
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(4146454)
0
15
0.00
0.41
0.0
1.9
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
0
16
0.00
0.41
0.0
5.6
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
0
16
0.00
0.41
0.0
1.2
—
—
—
0
0
(3010375) cycloSPORINE [Mass/volume] in Blood
0
17
0.00
0.41
0.0
34.9
—
133.6
—
0
17
(3000764) Benzodiazepines [Presence] in Urine
23
187
1.25
0.40
2.3
1.6
—
—
—
0
0
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
0
18
0.00
0.40
0.0
3.1
—
41.5
—
0
6
(3019832) Treponema pallidum Ab [Presence] in Serum
35
407
0.84
0.39
1.8
1.7
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
23
279
0.81
0.39
1.7
1.6
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
0
19
0.00
0.39
0.0
1.1
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
0
19
0.00
0.39
0.0
1.2
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
9
66
1.37
0.38
1.0
1.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
9
66
1.37
0.38
1.0
1.1
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
9
67
1.35
0.38
1.9
2.0
ug/l
2.1
5.2
—
9
61
(3013512) EKG study
64
577
1.14
0.37
3.8
3.3
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
35
301
1.18
0.37
1.6
3.9
umol/l
10.1
7.6
0.33
29
258
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
6
41
1.47
0.36
1.2
1.1
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
6
42
1.44
0.35
1.3
1.1
—
—
—
0
0
(4010399)
19
154
1.25
0.34
1.4
1.4
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
10
133
0.74
0.34
2.0
1.8
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
66
723
0.89
0.34
1.8
1.7
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
6
88
0.68
0.33
1.5
1.2
—
—
—
0
0
(4034850)
10
74
1.36
0.32
6.9
8.8
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
234
2403
0.90
0.32
4.0
3.9
mmol/l
1.4
1.5
1.24
220
2245
(3037522) Nuclear Ab [Titer] in Serum
41
363
1.15
0.31
1.2
1.5
titre
400.0
598.3
—
7
72
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
10
131
0.76
0.31
1.2
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
10
131
0.76
0.31
1.2
1.4
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
7
100
0.69
0.31
1.0
1.2
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
10
130
0.76
0.30
1.2
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
10
130
0.76
0.30
1.2
1.4
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
18
148
1.23
0.30
1.2
1.5
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
8
110
0.72
0.29
1.4
1.6
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
12
94
1.29
0.28
1.2
1.1
—
2.2
—
0
15
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
19
226
0.83
0.28
2.2
1.8
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
30
342
0.86
0.28
1.4
1.3
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
8
64
1.26
0.27
2.1
1.8
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
47
425
1.12
0.27
1.3
1.3
u/ml
3.5
7.0
0.74
14
170
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
8
66
1.22
0.27
1.3
1.3
—
2.8
—
0
10
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
8
66
1.22
0.27
2.1
1.7
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
25
216
1.17
0.26
3.6
3.4
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
10
78
1.29
0.24
5.4
10.6
%
1.9
1.6
—
10
73
(1002224) Polysomnography panel
15
124
1.22
0.24
1.1
1.1
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
6
85
0.70
0.24
1.3
1.4
—
—
—
0
0
(3000492) Spirometry study
28
247
1.15
0.23
1.3
1.4
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
5
38
1.32
0.23
1.6
1.6
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
7
92
0.76
0.23
1.1
1.1
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
7
93
0.75
0.22
1.1
1.1
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
7
94
0.74
0.22
1.1
1.1
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
11
135
0.81
0.22
3.5
1.9
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
80
753
1.08
0.22
2.6
2.4
u/l
57.5
56.9
0.04
68
702
(4306422)
5
41
1.22
0.22
1.0
1.2
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
11
0.00
0.21
0.0
2.8
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
11
0.00
0.21
0.0
2.8
—
—
—
0
0
(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.0
—
2.6
—
0
6
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.1
—
0.1
—
0
6
(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.1
—
0.4
—
0
6
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
11
89
1.24
0.21
1.5
1.7
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
5
43
1.17
0.21
1.0
1.0
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
21
183
1.16
0.20
1.0
1.0
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
6
48
1.25
0.20
3.3
3.8
%
56.8
54.5
—
6
48
(3030905) Polymorphonuclear cells [#/volume] in Blood
6
48
1.25
0.20
2.7
3.8
e9/l
3.8
4.1
—
6
48
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
0
14
0.00
0.20
0.0
4.4
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
0
14
0.00
0.20
0.0
4.4
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
6
49
1.23
0.20
1.8
1.1
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
6
49
1.23
0.20
1.8
1.2
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
6
51
1.18
0.19
1.2
1.1
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
10
81
1.24
0.19
1.4
1.7
u/ml
252.6
187.9
—
5
44
(3015235) Bicarbonate [Moles/volume] in Capillary blood
6
53
1.13
0.19
3.0
2.6
mmol/l
25.7
24.2
—
6
43
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
20
227
0.87
0.18
1.5
1.5
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
11
91
1.22
0.18
1.1
1.2
u/ml
0.5
0.6
—
6
62
(3007164) IgA [Mass/volume] in Serum or Plasma
73
694
1.07
0.16
1.6
1.5
g/l
2.2
2.1
0.46
43
399
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
59
557
1.07
0.16
1.6
1.7
—
—
—
0
0
(4035726)
20
178
1.13
0.15
1.5
1.5
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
36
388
0.92
0.15
3.7
3.7
%
25.9
20.8
—
10
156
(3019150) Specific gravity of Urine by Refractometry
53
560
0.94
0.14
4.2
3.3
kg/l
1.0
1.0
—
5
77
(3041096) Erythrocytes [Presence] in Urine by Automated
66
692
0.94
0.14
4.0
2.8
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
11
94
1.18
0.13
1.1
1.2
u/ml
3.5
4.3
—
5
69
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
10
85
1.18
0.12
1.3
1.6
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
215
2117
1.05
0.12
3.4
3.6
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
50
475
1.06
0.11
4.4
4.0
ug/l
1.8
2.4
0.36
44
428
(3021879) Hepatitis B virus core Ab [Presence] in Serum
26
241
1.09
0.10
1.6
1.5
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
27
290
0.92
0.10
1.2
1.2
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
43
452
0.94
0.10
1.6
1.5
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
236
2334
1.04
0.09
4.2
3.8
mmol/l
5.9
5.8
0.29
222
2164
(3044290) Cell count panel - Cerebral spinal fluid
5
46
1.09
0.09
1.2
3.7
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
5
46
1.09
0.09
1.0
1.1
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
229
2314
0.96
0.08
3.6
3.6
mmol/l
1.3
1.3
0.29
213
2156
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
12
107
1.13
0.08
1.5
1.3
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
17
185
0.91
0.08
2.9
3.0
e9/l
3.9
4.1
0.09
12
160
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
97
946
1.04
0.08
4.1
3.3
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
17
156
1.09
0.08
1.1
1.2
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
17
156
1.09
0.08
1.4
1.7
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
7
68
1.03
0.08
1.9
1.3
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
66
640
1.04
0.07
1.9
1.7
mmol/l
1.4
1.4
0.03
59
554
(3009542) Hematocrit [Volume Fraction] of Blood
257
2551
1.04
0.07
17.3
12.4
%
40.6
40.3
0.47
216
2074
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
9
86
1.05
0.07
1.1
1.7
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
80
780
1.03
0.07
3.4
3.1
ng/l
90.3
25.7
0.77
48
445
(1761868) Lipid panel - Serum or Plasma
93
950
0.97
0.06
2.4
2.5
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
74
758
0.97
0.06
1.3
1.4
u/ml
0.6
1.6
0.94
17
179
(3003694) ABO and Rh group [Type] in Blood
82
803
1.03
0.05
1.8
1.5
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
11
100
1.10
0.05
1.4
1.6
g/l
1.1
1.2
0.61
11
95
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
10
91
1.10
0.04
2.8
4.1
%
72.5
49.2
—
10
91
(3020961) Endomysium IgA Ab [Titer] in Serum
18
190
0.94
0.04
1.3
1.2
—
112.5
—
0
6
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
50
511
0.97
0.03
1.8
2.1
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
23
239
0.96
0.03
6.8
6.6
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
19
198
0.96
0.02
1.6
1.4
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
24
232
1.04
0.02
1.3
1.3
iu/ml
156.0
186.4
—
7
88
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
29
282
1.03
0.02
3.1
2.7
ug/l
0.8
0.7
0.28
15
162
(3003338) MCHC [Mass/volume]
241
2403
1.01
0.01
20.9
14.5
g/l
332.9
333.6
0.48
241
2393
(3013139) Helicobacter pylori Ag [Presence] in Stool
16
154
1.04
0.00
1.2
1.2
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
17
171
0.99
0.00
1.1
1.2
—
17.9
—
0
7
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
26
259
1.00
0.00
2.4
3.9
%
30.0
31.1
0.27
18
183
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
12
117
1.03
0.00
1.3
1.4
miu/ml
276.0
275.5
—
6
67
(3022145) Colonoscopy Study observation
29
287
1.01
0.00
1.3
1.3
—
—
—
0
0
(3022621) pH of Urine by Test strip
14
135
1.04
0.00
2.3
2.4
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
10
96
1.04
0.00
3.5
1.8
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
40
395
1.01
0.00
1.4
1.8
%
1.4
1.4
0.06
34
353
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
46
464
0.99
0.00
1.7
2.0
—
—
—
0
0
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
0
9
0.00
0.00
0.0
4.8
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
0
9
0.00
0.00
0.0
1.7
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
5
54
0.92
0.00
4.0
3.5
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
6
62
0.97
0.00
4.3
2.0
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
7
79
0.88
0.00
1.3
1.5
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
0
9
0.00
0.00
0.0
5.2
—
—
—
0
0
(3032352) Blasts [#/volume] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
9.3
—
—
—
0
0
(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.4
—
52.3
—
0
5
(3013637) Mi-2 Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3033882) Carnitine [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
2.3
—
35.1
—
0
7
(3019174) dRVVT (LA screen)
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3000722) Carnitine free (C0) [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
2.3
—
26.9
—
0
7
(3020650) Glucose [Presence] in Urine
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
18
180
1.00
0.00
2.2
2.4
ml/min/173m2
55.4
70.7
—
7
74
(44806071)
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3017115) Methotrexate [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
17.7
—
0.5
—
0
7
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection
0
5
0.00
0.00
0.0
5.6
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
5
55
0.91
0.00
1.0
1.3
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
0
7
0.00
0.00
0.0
8.1
—
—
—
0
0
(3006576) Bicarbonate [Moles/volume] in Blood
0
5
0.00
0.00
0.0
6.6
—
23.8
—
0
5
(3017509) Phencyclidine [Presence] in Urine
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
8
80
1.00
0.00
1.4
1.5
—
—
—
0
0
(3032868) Hemoglobin electrophoresis panel in Blood
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
0
8
0.00
0.00
0.0
2.5
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
8
81
0.99
0.00
1.4
1.4
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3022670) pH of Venous cord blood
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
5
59
0.85
0.00
1.0
1.6
—
—
—
0
0
(3011436) Histone Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
2.0
—
25.1
—
0
8
(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3036048) Francisella tularensis Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000919) Neutrophils/100 leukocytes in Pleural fluid
0
5
0.00
0.00
0.0
1.0
—
34.4
—
0
5
(3001556) Androgen free Index in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3049233) Organic acids panel - Urine
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection
0
5
0.00
0.00
0.0
5.6
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
3.9
—
—
—
0
0
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
8
0.00
0.00
0.0
1.0
—
25.1
—
0
8
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
9
95
0.95
0.00
1.4
1.6
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint Q17_OTHER_OSTEOCHONDROD and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| Q17_OTHER_OSTEOCHONDROD | 1.735 [1.24, 2.42] | 0.001 |
| Birth year | 0.989 [0.98, 1.0] | 0.011 |
During the follow-up period (1.1.1998 — 31.12.2019), 106 out of 1266 females with Q17_OTHER_OSTEOCHONDROD died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| Q17_OTHER_OSTEOCHONDROD | 1.75 [1.36, 2.26] | < 0.001 |
| Birth year | 0.987 [0.98, 1.0] | 0.006 |
During the follow-up period (1.1.1998 — 31.12.2019), 87 out of 1206 males with Q17_OTHER_OSTEOCHONDROD died.
Mortality risk
Mortality risk for people of age
years, who have Q17_OTHER_OSTEOCHONDROD.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.14% | 0.289% |
| 5 | 0.742% | 1.79% |
| 10 | 2.147% | 4.824% |
| 15 | 3.782% | 9.297% |
| 20 | 6.659% | 15.819% |
Relationships between endpoints
↥Index endpoint: Q17_OTHER_OSTEOCHONDROD – Other osteochondrodysplasias
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data